We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
10 Year Est. Return
AUM
$257M
AUM Growth
-$13.3M
Cap. Flow
-$15.3M
Cap. Flow %
-5.95%
Top 10 Hldgs %
43.17%
Holding
259
New
67
Increased
65
Reduced
68
Closed
57

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.62M
2
MCD icon
McDonald's
MCD
+$2.54M
3
MDLZ icon
Mondelez International
MDLZ
+$2.52M
4
CI icon
Cigna
CI
+$2.32M
5
JPM icon
JPMorgan Chase
JPM
+$2.18M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Financials 13.15%
3 Healthcare 9.82%
4 Consumer Discretionary 6.3%
5 Industrials 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXP icon
176
Eagle Materials
EXP
$6.45B
$375K 0.15%
1,724
+316
+22% +$77.4K
PR
177
Permian Resources
PR
$18B
$370K 0.14%
+22,894
New +$379K
REGN icon
178
Regeneron Pharmaceuticals
REGN
$83.2B
$367K 0.14%
349
-257
-42% -$249K
BIRK icon
179
Birkenstock
BIRK
$6.96B
$365K 0.14%
+6,701
New +$332K
WGS icon
180
GeneDx Holdings
WGS
$2.45B
$363K 0.14%
+13,875
New +$263K
LECO icon
181
Lincoln Electric
LECO
$15.5B
$354K 0.14%
1,875
+418
+29% +$90.7K
NVCR icon
182
NovoCure
NVCR
$2.04B
$349K 0.14%
+20,353
New +$358K
MAX icon
183
MediaAlpha
MAX
$802M
$348K 0.14%
+26,391
New +$486K
AYI icon
184
Acuity Brands
AYI
$10.8B
$336K 0.13%
1,392
-789
-36% -$202K
TMHC
185
DELISTED
Taylor Morrison
TMHC
$335K 0.13%
6,034
-4,320
-42% -$247K
RITM icon
186
Rithm Capital
RITM
$5.76B
$333K 0.13%
+30,518
New +$338K
JBL icon
187
Jabil
JBL
$37.1B
$326K 0.13%
3,001
+696
+30% +$84.4K
GWW icon
188
W.W. Grainger
GWW
$61.5B
$323K 0.13%
358
+64
+22% +$60.2K
BCC icon
189
Boise Cascade
BCC
$2.98B
$318K 0.12%
2,671
+753
+39% +$102K
TDG icon
190
TransDigm Group
TDG
$68.8B
$313K 0.12%
+245
New +$314K
BLDR icon
191
Builders FirstSource
BLDR
$8.03B
$313K 0.12%
2,259
+526
+30% +$89.3K
WSO icon
192
Watsco Inc
WSO
$13.3B
$309K 0.12%
667
+147
+28% +$67.2K
KBH icon
193
KB Home
KBH
$3.55B
$308K 0.12%
+4,390
New +$299K
AMG icon
194
Affiliated Managers Group
AMG
$9.61B
$302K 0.12%
+1,933
New +$308K
OC icon
195
Owens Corning
OC
$12.5B
$300K 0.12%
1,726
-874
-34% -$151K
RLI icon
196
RLI Corp
RLI
$5.89B
$296K 0.11%
4,202
+934
+29% +$66.8K
IBP icon
197
Installed Building Products
IBP
$6.47B
$288K 0.11%
1,402
-655
-32% -$148K
SITE icon
198
SiteOne Landscape Supply
SITE
$4.33B
$285K 0.11%
2,345
+540
+30% +$81.7K
TRV icon
199
Travelers Companies
TRV
$78.7B
$221K 0.09%
1,085
MTDR icon
200
Matador Resources
MTDR
$6.48B
$213K 0.08%
3,571
-2,653
-43% -$167K

Similar funds

Alpha DNA Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Alpha DNA Investment Management held 259 positions worth $257M, down 4.9% from $271M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Alpha DNA Investment Management withdrew a net $15.3M in Q2 2024, closing 57 positions and reducing 68 holdings. Its most notable exit was Cigna, an estimated $2.32M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Alpha DNA Investment Management opened a new position in Colgate-Palmolive worth $2.32M.

  • Alpha DNA Investment Management's largest Q2 2024 buy was Colgate-Palmolive: 23,939 shares worth $2.32M.
  • Alpha DNA Investment Management added most to Wells Fargo in Q2 2024, an estimated $2.53M increase.
  • Alpha DNA Investment Management's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.62M.
  • Alpha DNA Investment Management fully exited Cigna in Q2 2024, selling an estimated $2.32M.
  • Alpha DNA Investment Management's ten largest holdings make up 43% of its $257M portfolio in Q2 2024.
  • Alpha DNA Investment Management opened 67 new positions and closed 57 in Q2 2024.
  • Alpha DNA Investment Management's portfolio value fell 4.9% quarter-over-quarter to $257M.

Based on Alpha DNA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.